447 filings
Page 4 of 23
6-K
lpa3t898u73pd1s yw
30 Mar 21
Announcements of holders of considerable holdings according to article 43 WpHG
7:21am
6-K
jlmmkwr16ed np0f7t0n
16 Mar 21
Adjustment of the conversion price
6:21am
6-K
83i6dc82k4 bb41bv
4 Mar 21
Current report (foreign)
6:05am
6-K
ggxx3wg055ylga3t3
3 Mar 21
Current report (foreign)
2:52pm
6-K
8n00jhvv7jb267e324c
3 Mar 21
Voting Rights Announcement
2:49pm
6-K
a5k32
1 Mar 21
Current report (foreign)
1:09pm
6-K
f4ar7xk7
26 Feb 21
Current report (foreign)
4:52pm
6-K
fur4aqfe7rr6l
26 Feb 21
Biofrontera AG announces the closing of the capital raise with gross proceeds of EUR 24.7 million
10:28am
424B5
3rdf2ewbd56
25 Feb 21
Prospectus supplement for primary offering
4:27pm
SC 13D/A
npuiobw e8c
25 Feb 21
Biofrontera / Maruho ownership change
4:06pm
6-K
dh4md q45r
25 Feb 21
Current report (foreign)
3:34pm
6-K
2bsg4od8
25 Feb 21
Current report (foreign)
12:41pm
6-K
j21uu1
25 Feb 21
Business news for the stock market
11:12am
6-K
lcdirw8 c3
25 Feb 21
Current report (foreign)
6:04am
6-K
tcya 7vxfs
25 Feb 21
Current report (foreign)
6:01am
6-K
urzqjc wh5ij2357cz
24 Feb 21
Biofrontera submits study report of pharmacokinetics study to FDA
10:36am
6-K
pckkeuc44 qu
24 Feb 21
Biofrontera AG Announces Pricing of US$8.9 Million Firm Commitment Public Offering of American Depositary Shares
6:12am
6-K
d7vbtqe8ubo91uphz3f
24 Feb 21
Current report (foreign)
6:06am
6-K
oq75uti6if6hr
18 Feb 21
Managers’ transactions announcement according to article 19 MAR
3:18pm
6-K
vezfnh3 zb1bwoup3
18 Feb 21
Managers’ transactions announcement according to article 19 MAR
3:14pm